ARISj™

Japanese Adverse Event Reporting System

Global pharmacovigilance requires collaboration between all major ICH regions.

ARISj, a Japanese (Kanji) based system, is the perfect solution for organizations working with, or partnering with, Japanese companies and affiliates. Supporting all domestic reporting requirements, ARISj enables the user to establish a worldwide platform for pharmacovigilance. The latest version supports all the recent MHLW legislation and supports all domestic reporting obligations.

ARISg and ARISj can be deployed in a decentralized environment or with one central database, allowing all configuration including workflow and data entry templates to only be set up once and be easily shared by all your global affiliates.

Together with ARISg, ARISj is the only proven solution for international companies wanting to establish a global pharmacovigilance program. The system has been successfully deployed at many of the leading Japanese Pharma companies enabling them to support both their domestic MHLW and international reporting obligations.